Understanding OUR Cytokine-Based Immunotherapy Candidates Our Determination extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure solutions remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/shib-or-doge-which-one-could-outperform-dtx-exchange-in-2025/